DOI · e01.org

Preliminary Results about Application of Intensity-Modulated Radiotherapy to Reduce Prophylactic Radiation Dose in Limited-Stage Small Cell Lung Cancer

Zhiyan Liu, Jing Wang, Zhiyong Yuan, Baozhong Zhang, Linlin Gong, Lujun Zhao, Ping Wang · Journal of Cancer · 2018

  • DOI 10.7150/jca.24976
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2018

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2018

Abstract

To evaluate the clinical outcomes of simultaneous dose reduction of elective nodal area with intensity-modulated radiotherapy (SIR-IMRT) versus conventional IMRT (C-IMRT) in patients with limited-stage small-cell lung cancer (LS-SCLC), patients with LS-SCLC who received definitive SIR-IMRT or C-IMRT were retrospectively analyzed.In SIR-IMRT group, the prescribed dose was 60Gy to the planning gross target volume (PTV G ), and 54Gy to the planning target volume (PTV).In the C-IMRT group, the prescribed dose was 60Gy to the whole PTV.Radiation-related toxicities were estimated according to Common Terminology Criteria for Adverse Events (version 3.0).The primary endpoint was loco-regional recurrence-free survival (LRFS), and the secondary endpoints include overall survival (OS) and toxicities.LRFS and OS were estimated with Kaplan-Meier method.After propensity score matching, 84 patients were included in this study, with 42 patients in each group.Fifty-eight patients experienced treatment failure.Grade 3 and above radiation-induced lung toxicity developed in 2 patients in SIR-IMRT group and 5 patients in C-IMRT group, respectively.Grade 3 and above radiation-related esophagitis was observed in 3 patients and 5 patients, respectively.The 1-, 3-year LRFS rates of the SIR-IMRT group and C-IMRT group were 90.4%, 73.3% and 87.1%, 45.0%(P=0.025),respectively.Reducing the irradiation dose to the elective nodal region may reduce radiation-induced toxicities without compromising local-regional control and overall survival.

Open the resolved locator · 10.7150/jca.24976

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:21 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v09p2625.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.